CORRECTION: CSMS #50183808 – GUIDANCE: Section 301 China Extension of Product Exclusions
The purpose of this message is to provide guidance regarding the extension of product exclusions from additional Section 301 China duties on certain medical-care products to address COVID-19.
On November 16, 2021, the USTR published 86 FR 63438, providing a 16-day transition period for all COVID exclusions through November 30, 2021, and extending 81 of the COVID exclusions for an additional 6 months.
The 16-day transition period will extend through November 30, 2021, and 81 COVID exclusions will be further extended through May 31, 2022.
The exclusions listed are available for any product that meets the description as set out in the Annexes to 86 FR 63438, regardless of whether the importer filed an exclusion request. Further, the scope of each exclusion is governed by the scope of the 10-digit HTS headings and product descriptions provided in the Annexes to 86 FR 63438, not by the product descriptions set out in any particular request for exclusion.
The functionality for the acceptance of the extended product exclusions will be available in the Automated Commercial Environment (ACE) as of 7 am eastern standard time, November 18, 2021. Exclusion HTS subheading 9903.88.66 will be available in ACE as of 12 am December 1, 2021.
Instructions for importers, brokers, and filers on submitting entries to CBP containing granted exclusions by the USTR from the Section 301 measures can be found here.
Source: U.S. Customs and Border Protection (CBP)
Back to Farrow News